Contineum Therapeutics (CTNM) Return on Sales (2023 - 2024)
Contineum Therapeutics' Return on Sales history spans 2 years, with the latest figure at 0.01% for Q2 2024.
- Quarterly Return on Sales fell 1.0% to 0.01% in Q2 2024 from the year-ago period, while the trailing twelve-month figure was 0.01% through Jun 2024, changed N/A year-over-year, with the annual reading at 0.0% for FY2023, N/A changed from the prior year.
- Return on Sales came in at 0.01% for Q2 2024, down from 0.01% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q2 2023 to a low of 0.01% in Q2 2024.